Renalase is an α-NAD(P)H oxidase/anomerase

被引:0
|
作者
机构
[1] Beaupre, Brett A.
[2] Carmichael, Brenton R.
[3] Hoag, Matthew R.
[4] Shah, Dhara D.
[5] Moran, Graham R.
来源
Moran, G.R. (moran@uwm.edu) | 1600年 / American Chemical Society卷 / 135期
关键词
Renalase is a protein hormone secreted into the blood by the kidney that is reported to lower blood pressure and slow heart rate. Since its discovery in 2005; renalase has been the subject of conjecture pertaining to its catalytic function. While it has been widely reported that renalase is the third monoamine oxidase (monoamine oxidase C) that oxidizes circulating catecholamines such as epinephrine; there has been no convincing demonstration of this catalysis in vitro. Renalase is a flavoprotein whose structural topology is similar to known oxidases; lysine demethylases; and monooxygenases; but its active site bears no resemblance to that of any known flavoprotein. We have identified the catalytic activity of renalase as an α-NAD(P)H oxidase/anomerase; whereby low equilibrium concentrations of the α-anomer of NADPH and NADH initiate rapid reduction of the renalase flavin cofactor. The reduced cofactor then reacts with dioxygen to form hydrogen peroxide and releases nicotinamide dinucleotide product in the β-form. These processes yield an apparent turnover number (0.5 s-1 in atmospheric dioxygen) that is at least 2 orders of magnitude more rapid than any reported activity with catechol neurotransmitters. This highly novel activity is the first demonstration of a role for naturally occurring α-NAD(P)H anomers in mammalian physiology and the first report of a flavoprotein catalyzing an epimerization reaction. © 2013 American Chemical Society;
D O I
暂无
中图分类号
学科分类号
摘要
Journal article (JA)
引用
收藏
相关论文
共 50 条
  • [41] A role of vascular NAD(P)H oxidase in diabetic vascular complications
    Inoguchi, T
    Nawata, H
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 52P - 52P
  • [42] A novel superoxide-producing NAD(P)H oxidase in kidney
    Shiose, A
    Kuroda, J
    Tsuruya, K
    Hirai, M
    Hirakata, H
    Naito, S
    Hattori, M
    Sakaki, Y
    Sumimoto, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) : 1417 - 1423
  • [43] The failing human heart - Another battlefield for the NAD(P)H oxidase?
    Warnholtz, A
    Munzel, T
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) : 2172 - 2174
  • [44] PPARγ and NAD(P)H oxidase system interaction in glycerol-induced acute renal failure: role of gp91phox subunit of NAD(P)H oxidase
    Newaz, Mohammad
    Yousefipour, Zivar
    RENAL FAILURE, 2014, 36 (04) : 567 - 574
  • [45] Bacterial Renalase: Structure and Kinetics of an Enzyme with 2-and 6-Dihydro-β-NAD(P) Oxidase Activity from Pseudomonas phaseolicola
    Hoag, Matthew R.
    Roman, Joseph
    Beaupre, Brett A.
    Silvaggi, Nicholas R.
    Moran, Graham R.
    BIOCHEMISTRY, 2015, 54 (24) : 3791 - 3802
  • [46] The phagocytic NAD(P)H-oxidase: Heterologous expression of membrane flavohemoprotein
    Lamanuzzi, Leila B.
    Bizouarn, Tania
    Baciou, Laura
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2008, 1777 : S59 - S59
  • [47] Vascular NAD(P)H oxidase as a novel therapeutic target in vascular disease
    Brosnan, J
    DRUG NEWS & PERSPECTIVES, 2004, 17 (07) : 429 - 434
  • [48] Oxidative stress-associated vascular aging is xanthine oxidase but not NAD(P)H oxidase dependent
    Newaz, M
    Yousefipour, Z
    Johnson, R
    Oyekan, A
    HYPERTENSION, 2005, 46 (04) : 844 - 845
  • [49] Angiotensin II stimulation of NAD(P)H oxidase activity - Upstream mediators
    Seshiah, PN
    Weber, DS
    Rocic, P
    Valppu, L
    Taniyama, Y
    Griendling, KK
    CIRCULATION RESEARCH, 2002, 91 (05) : 406 - 413
  • [50] Application of NAD(P)H oxidase for cofactor regeneration in dehydrogenase catalyzed oxidations
    Rehn, Gustav
    Pedersen, Asbjorn Toftgaard
    Woodley, John M.
    JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC, 2016, 134 : 331 - 339